Dexcom (DXCM) 79.40 $DXCM
Country Music Star Eric Paslay Partners with Dexcom to Share His Story and Help Others Living with Diabetes
PR Newswire - Wed Jul 06, 7:30AM CDT
Dexcom, Inc., (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced it has partnered with Platinum-selling country music singer-songwriter Eric Paslay, who has Type 1 Diabetes, to raise awareness of the benefits of CGM for people living with the disease. Paslay will work with Dexcom to share his personal experience with diabetes and how proper glucose management has allowed him to live life to the fullest without limitations.
DXCM: 79.40 (+0.53)
DexCom Schedules Second Quarter 2016 Earnings Release and Conference Call for August 2, 2016 at 4:30 p.m. Eastern Time
BusinessWire - Fri Jul 01, 7:00AM CDT
DexCom, Inc. (NASDAQ
XCM) today announced that it plans to release its second quarter 2016 financial results after market close on Tuesday, August 2, 2016. Management will hold a conference call to review the company's second quarter 2016 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference.
DXCM: 79.40 (+0.53)
DexCom Set to Possibly Pullback After Yesterday's Rally of 4.28%
Comtex SmarTrend(R) - Wed Jun 08, 2:08PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $68.28 to a high of $72.19. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $69.08 on volume of 801,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DXCM: 79.40 (+0.53)
SmarTrend Watching for Potential Pullback in Shares of DexCom After 1.32% Gain
Comtex SmarTrend(R) - Wed Jun 01, 2:07PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $62.68 to a high of $65.60. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $65.43 on volume of 718,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DXCM: 79.40 (+0.53)
DexCom Announces Upcoming Conference Presentations
BusinessWire - Tue May 17, 7:00AM CDT
DexCom, Inc. (NASDAQXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:
DXCM: 79.40 (+0.53)
Dexcom, Inc. Announces Acquisition of its Distributor in Germany, Switzerland and Austria
BusinessWire - Mon May 02, 3:05PM CDT
Dexcom, Inc. (NASDAQXCM) announced today that it has entered into a definitive agreement to acquire Nintamed, a distribution company with presence in Germany, Switzerland and Austria. Nintamed has served as Dexcom's exclusive distributor in these countries for six years.
DXCM: 79.40 (+0.53)
DexCom (DXCM) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:46AM CDT
Shares of DexCom Inc. (DXCM) fell 3.6% to close at $65.96 on Apr 28, following a disappointing first-quarter 2016 earnings release.
ANTM: 131.56 (-0.59), DXCM: 79.40 (+0.53), INGN: 51.82 (-0.09), EXAC: 27.35 (+0.23)
Are DexCom's Best Days Behind It, or Still to Come?
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 28, 6:20PM CDT
Image source: Dexcom, Inc. Worry that its valuation had run too far, too fast has resulted in DexCom 's shares tumbling from more than $100 last September to less than $70. However, the maker of medical devices that help diabetics better track...
DXCM: 79.40 (+0.53)
Dexcom, Inc. Issues Press Release To Supplement Previous Customer Notification
PR Newswire - Mon Apr 11, 4:36PM CDT
Dexcom, Inc. (NASDAQ: DXCM) issues this press release to supplement its previous customer notification and remind its patients to periodically test the audible alarms and alerts on certain receivers manufactured by Dexcom to make sure that the audible alarms and alerts are functioning properly. The notification constituted a voluntary recall and applied to those Dexcom G4 Platinum Receivers, Dexcom G4 Platinum Pediatric Receivers, Dexcom G4 Platinum Professional Receivers, Dexcom G4 Platinum with Share Receivers, Dexcom G4 Platinum with Share Pediatric Receivers and the Dexcom G5 Mobile Receivers that are experiencing problems with audible alarms and alerts. There is no reason for patients to return receivers to Dexcom that are functioning properly.
DXCM: 79.40 (+0.53)
Watch for DexCom to Potentially Pullback After Gaining 5.29% Yesterday
Comtex SmarTrend(R) - Mon Apr 04, 3:27PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $67.63 to a high of $71.49. Yesterday, the shares gained 5.3%, which took the trading range above the 3-day high of $69.37 on volume of 566,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DXCM: 79.40 (+0.53)
DexCom Schedules First Quarter 2016 Earnings Release and Conference Call for April 27, 2016 at 4:30 p.m. Eastern Time
BusinessWire - Fri Apr 01, 7:00AM CDT
DexCom, Inc. (NASDAQXCM) today announced that it plans to release its first quarter 2016 financial results after market close on Wednesday, April 27, 2016. Management will hold a conference call to review the company's first quarter 2016 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference.
DXCM: 79.40 (+0.53)
DexCom Rises 4.94% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Mar 22, 3:28PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $59.42 to a high of $62.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $61.27 on volume of 366,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DXCM: 79.40 (+0.53)
DexCom Launches G5 PLATINUM CGM App on Apple Watch
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 12:20PM CDT
DexCom (DXCM) recently announced that its G5 PLATINUM Continuous Glucose Monitoring (CGM) System with Share app will be available on Apple Watch.
ABMD: 115.94 (+1.79), DXCM: 79.40 (+0.53), LMNX: 21.72 (+0.06), AAPL: 96.98 (+0.30)
Dexcom G5® Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch
PR Newswire - Mon Mar 14, 1:37PM CDT
Dexcom, Inc., (NASDAQXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System will support the Apple Watch enabling users to monitor their G5 Mobile glucose data using the app with one glance of their wrist. Users, as well as parents and caregivers, will be able to discreetly receive glucose readings and trends, alerts and notifications on Apple Watch, which syncs data directly from iPhone.
DXCM: 79.40 (+0.53)
The Motley Fool Sits Down With the CEO of Dexcom Inc.
Brian Feroldi, The Motley Fool - Motley Fool - Sun Mar 13, 2:03PM CDT
Image source: Dexcom. The Centers for Diseases Control and Prevention estimates that more than 29 million Americans have diabetes, a chronic disease that inhibits the body's ability to produce or effectively utilize insulin. Patients with diabetes...
JNJ: 122.93 (+0.08), DXCM: 79.40 (+0.53), MDT: 88.51 (+0.15), TNDM: 7.70 (-0.01), GOOGL: 727.20 (+9.42), GOOG: 715.09 (+9.46)
Is This the Best Stock to Invest in Diabetes?
Todd Campbell, The Motley Fool - Motley Fool - Sat Mar 12, 7:40AM CST
Image source: DexCom. Estimates suggesting that over 200 million more people could suffer from diabetes in the next 20 years than suffer from it today have interest in diabetes-treatment companies soaring. Although much of that interest surrounds...
DXCM: 79.40 (+0.53)
UPDATED PRESENTATION TIME: DexCom Announces Upcoming Conference Presentation
BusinessWire - Tue Feb 09, 3:30PM CST
DexCom, Inc. (NASDAQXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
DXCM: 79.40 (+0.53)
Why DexCom, Inc. Shares Fell 21% Today
Todd Campbell, The Motley Fool - Motley Fool - Mon Feb 08, 1:19PM CST
Image source: DexCom. What: After investment firm Robert W. Baird downgraded the stock from outperform to neutral, shares in DexCom were down 21.5% at 2:00 p.m. ET today. So what: Despite reporting at the J.P. Morgan healthcare conference...
DXCM: 79.40 (+0.53)
Country Music Star Eric Paslay Partners with Dexcom to Share His Story and Help Others Living with Diabetes
PR Newswire - Wed Jul 06, 7:30AM CDT
Dexcom, Inc., (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced it has partnered with Platinum-selling country music singer-songwriter Eric Paslay, who has Type 1 Diabetes, to raise awareness of the benefits of CGM for people living with the disease. Paslay will work with Dexcom to share his personal experience with diabetes and how proper glucose management has allowed him to live life to the fullest without limitations.
DXCM: 79.40 (+0.53)
DexCom Schedules Second Quarter 2016 Earnings Release and Conference Call for August 2, 2016 at 4:30 p.m. Eastern Time
BusinessWire - Fri Jul 01, 7:00AM CDT
DexCom, Inc. (NASDAQ
XCM) today announced that it plans to release its second quarter 2016 financial results after market close on Tuesday, August 2, 2016. Management will hold a conference call to review the company's second quarter 2016 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference. DXCM: 79.40 (+0.53)
DexCom Set to Possibly Pullback After Yesterday's Rally of 4.28%
Comtex SmarTrend(R) - Wed Jun 08, 2:08PM CDT
DexCom (NASDAQ
XCM) traded in a range yesterday that spanned from a low of $68.28 to a high of $72.19. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $69.08 on volume of 801,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DXCM: 79.40 (+0.53)
SmarTrend Watching for Potential Pullback in Shares of DexCom After 1.32% Gain
Comtex SmarTrend(R) - Wed Jun 01, 2:07PM CDT
DexCom (NASDAQ
XCM) traded in a range yesterday that spanned from a low of $62.68 to a high of $65.60. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $65.43 on volume of 718,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DXCM: 79.40 (+0.53)
DexCom Announces Upcoming Conference Presentations
BusinessWire - Tue May 17, 7:00AM CDT
DexCom, Inc. (NASDAQ
XCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: DXCM: 79.40 (+0.53)
Dexcom, Inc. Announces Acquisition of its Distributor in Germany, Switzerland and Austria
BusinessWire - Mon May 02, 3:05PM CDT
Dexcom, Inc. (NASDAQ
XCM) announced today that it has entered into a definitive agreement to acquire Nintamed, a distribution company with presence in Germany, Switzerland and Austria. Nintamed has served as Dexcom's exclusive distributor in these countries for six years. DXCM: 79.40 (+0.53)
DexCom (DXCM) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:46AM CDT
Shares of DexCom Inc. (DXCM) fell 3.6% to close at $65.96 on Apr 28, following a disappointing first-quarter 2016 earnings release.
ANTM: 131.56 (-0.59), DXCM: 79.40 (+0.53), INGN: 51.82 (-0.09), EXAC: 27.35 (+0.23)
Are DexCom's Best Days Behind It, or Still to Come?
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 28, 6:20PM CDT
Image source: Dexcom, Inc. Worry that its valuation had run too far, too fast has resulted in DexCom 's shares tumbling from more than $100 last September to less than $70. However, the maker of medical devices that help diabetics better track...
DXCM: 79.40 (+0.53)
Dexcom, Inc. Issues Press Release To Supplement Previous Customer Notification
PR Newswire - Mon Apr 11, 4:36PM CDT
Dexcom, Inc. (NASDAQ: DXCM) issues this press release to supplement its previous customer notification and remind its patients to periodically test the audible alarms and alerts on certain receivers manufactured by Dexcom to make sure that the audible alarms and alerts are functioning properly. The notification constituted a voluntary recall and applied to those Dexcom G4 Platinum Receivers, Dexcom G4 Platinum Pediatric Receivers, Dexcom G4 Platinum Professional Receivers, Dexcom G4 Platinum with Share Receivers, Dexcom G4 Platinum with Share Pediatric Receivers and the Dexcom G5 Mobile Receivers that are experiencing problems with audible alarms and alerts. There is no reason for patients to return receivers to Dexcom that are functioning properly.
DXCM: 79.40 (+0.53)
Watch for DexCom to Potentially Pullback After Gaining 5.29% Yesterday
Comtex SmarTrend(R) - Mon Apr 04, 3:27PM CDT
DexCom (NASDAQ
XCM) traded in a range yesterday that spanned from a low of $67.63 to a high of $71.49. Yesterday, the shares gained 5.3%, which took the trading range above the 3-day high of $69.37 on volume of 566,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DXCM: 79.40 (+0.53)
DexCom Schedules First Quarter 2016 Earnings Release and Conference Call for April 27, 2016 at 4:30 p.m. Eastern Time
BusinessWire - Fri Apr 01, 7:00AM CDT
DexCom, Inc. (NASDAQ
XCM) today announced that it plans to release its first quarter 2016 financial results after market close on Wednesday, April 27, 2016. Management will hold a conference call to review the company's first quarter 2016 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference. DXCM: 79.40 (+0.53)
DexCom Rises 4.94% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Mar 22, 3:28PM CDT
DexCom (NASDAQ
XCM) traded in a range yesterday that spanned from a low of $59.42 to a high of $62.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $61.27 on volume of 366,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DXCM: 79.40 (+0.53)
DexCom Launches G5 PLATINUM CGM App on Apple Watch
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 12:20PM CDT
DexCom (DXCM) recently announced that its G5 PLATINUM Continuous Glucose Monitoring (CGM) System with Share app will be available on Apple Watch.
ABMD: 115.94 (+1.79), DXCM: 79.40 (+0.53), LMNX: 21.72 (+0.06), AAPL: 96.98 (+0.30)
Dexcom G5® Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch
PR Newswire - Mon Mar 14, 1:37PM CDT
Dexcom, Inc., (NASDAQ
XCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System will support the Apple Watch enabling users to monitor their G5 Mobile glucose data using the app with one glance of their wrist. Users, as well as parents and caregivers, will be able to discreetly receive glucose readings and trends, alerts and notifications on Apple Watch, which syncs data directly from iPhone. DXCM: 79.40 (+0.53)
The Motley Fool Sits Down With the CEO of Dexcom Inc.
Brian Feroldi, The Motley Fool - Motley Fool - Sun Mar 13, 2:03PM CDT
Image source: Dexcom. The Centers for Diseases Control and Prevention estimates that more than 29 million Americans have diabetes, a chronic disease that inhibits the body's ability to produce or effectively utilize insulin. Patients with diabetes...
JNJ: 122.93 (+0.08), DXCM: 79.40 (+0.53), MDT: 88.51 (+0.15), TNDM: 7.70 (-0.01), GOOGL: 727.20 (+9.42), GOOG: 715.09 (+9.46)
Is This the Best Stock to Invest in Diabetes?
Todd Campbell, The Motley Fool - Motley Fool - Sat Mar 12, 7:40AM CST
Image source: DexCom. Estimates suggesting that over 200 million more people could suffer from diabetes in the next 20 years than suffer from it today have interest in diabetes-treatment companies soaring. Although much of that interest surrounds...
DXCM: 79.40 (+0.53)
UPDATED PRESENTATION TIME: DexCom Announces Upcoming Conference Presentation
BusinessWire - Tue Feb 09, 3:30PM CST
DexCom, Inc. (NASDAQ
XCM) today announced that management will present an update on DexCom at the following upcoming investor conference: DXCM: 79.40 (+0.53)
Why DexCom, Inc. Shares Fell 21% Today
Todd Campbell, The Motley Fool - Motley Fool - Mon Feb 08, 1:19PM CST
Image source: DexCom. What: After investment firm Robert W. Baird downgraded the stock from outperform to neutral, shares in DexCom were down 21.5% at 2:00 p.m. ET today. So what: Despite reporting at the J.P. Morgan healthcare conference...
DXCM: 79.40 (+0.53)
